Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. by Zahra Motahari (6814013)

Subjects:

The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells. by Zahra Motahari (6814013)

Subjects:

PAM16 correlation with N-MYC. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition on mitochondrial activity in medulloblastoma cells. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition reduces DAOY cells migration. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition induces medulloblastoma cell death. by Zahra Motahari (6814013)

Subjects:

BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

Subjects:

Expression of MAGMAS in medulloblastoma. by Zahra Motahari (6814013)

Subjects:

BT9 exhibits a dose- and time-dependent cytotoxic effect on medulloblastoma. by Zahra Motahari (6814013)

Subjects:

Association of <i>Shigella</i> infections with EE biomarker concentration over time. by Haley A. Liakakos (21445884)

Subjects:

Associations between <i>Shigella</i> infections and EE biomarker concentrations from time of index subclinical <i>Shigella</i> detection through 6-months post-detection, stratified... by Haley A. Liakakos (21445884)

Subjects:

TMS recapitulates epigenetic age predictions and tissue-dependent effects identified via other technologies. by Amy Longtin (21409957)

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000 in Adults in the Metropolitan and Non-metropolitan areas in the United States, 1999 to 2... by Aman Goyal (19231397)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

OPV coverage by nationwide and at study areas (as per enrollment period). by Zahid Hasan Khan (6281396)

Subjects:

Reasons given by parents/guardians of incompletely vaccinated children (Zero-dose and one-dose OPV vaccination). by Zahid Hasan Khan (6281396)

Subjects:

Distribution of background characteristics of the study participants (N = 18255). by Zahid Hasan Khan (6281396)

Subjects:

Differential miRNA target gene pathway enrichment bubble map. by Zhaowen Tan (12283502)

Subjects: